Translating Discovery Into Care: Professor Stephen Maher On The Future Of Cancer Therapy

In today’s episode, we’re joined by Professor Stephen Maher, an expert in translational oncology and radiation research at Trinity College Dublin. As Director of Postgraduate Studies at the School of Medicine, Stephen’s groundbreaking research focuses on why some cancers respond to treatments while others resist — especially in relation to chemotherapy and radiotherapy.

🎶https://tinyurl.com/4jvbmpcf

Stephen’s work sheds light on how factors like microRNAs, DNA damage response, and tumor hypoxia impact treatment sensitivity, with a focus on oesophageal and pancreatic cancers.

🎧 What you’ll learn:
🧬 The future of anti-cancer therapeutics
💡 The evolving landscape of radiation research
🩺 Why translational oncology is crucial for improving patient outcomes

With a Ph.D. in Oncology and fellowship at the National Cancer Institute, Stephen leads national and international collaborations to bridge lab-based discoveries with real-world patient care.

👨‍🔬 Click learn more https://www.tcd.ie/research/profiles/?profile=maherst

🎧 Listen now on Apple Podcasts: http://apple.co/30PvU9C